ChunLab Inc
CJ Bioscience, Inc. provides microbiome solutions to address unmet medical needs in South Korea and internationally. The company's platform is Ez-Mx, a bioinformatics-based platform for microbiome data analysis. Its product pipeline includes CJRB-101 that is phase I clinical trial for solid tumors; CJRB-201, CJRB-202, and CJRB-203 for inflammatory bowel diseases; CJRB-302 for Parkinson's diseases… Read more
Market Cap & Net Worth: ChunLab Inc (311690)
ChunLab Inc (KQ:311690) has a market capitalization of $71.83 Million (₩105.18 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24500 globally and #1418 in its home market, demonstrating a -1.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ChunLab Inc's stock price ₩8050.00 by its total outstanding shares 13065462 (13.07 Million).
ChunLab Inc Market Cap History: 2019 to 2026
ChunLab Inc's market capitalization history from 2019 to 2026. Data shows change from $294.22 Million to $71.83 Million (-20.56% CAGR).
Index Memberships
ChunLab Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.01% | #715 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.01% | #715 of 1384 |
Weight: ChunLab Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ChunLab Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ChunLab Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
ChunLab Inc's market cap is 0.03 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $294.22 Million | $4.78 Billion | -$4.35 Billion | 0.06x | N/A |
| 2020 | $400.64 Million | $5.31 Billion | -$8.76 Billion | 0.08x | N/A |
| 2021 | $381.08 Million | $4.36 Billion | -$19.27 Billion | 0.09x | N/A |
| 2022 | $226.93 Million | $4.07 Billion | -$34.91 Billion | 0.06x | N/A |
| 2023 | $144.02 Million | $5.58 Billion | -$22.91 Billion | 0.03x | N/A |
| 2024 | $90.04 Million | $3.47 Billion | -$32.84 Billion | 0.03x | N/A |
Competitor Companies of 311690 by Market Capitalization
Companies near ChunLab Inc in the global market cap rankings as of March 19, 2026.
Key companies related to ChunLab Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ChunLab Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, ChunLab Inc's market cap moved from $294.22 Million to $ 71.83 Million, with a yearly change of -20.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩71.83 Million | -13.63% |
| 2025 | ₩83.16 Million | -7.63% |
| 2024 | ₩90.04 Million | -37.48% |
| 2023 | ₩144.02 Million | -36.53% |
| 2022 | ₩226.93 Million | -40.45% |
| 2021 | ₩381.08 Million | -4.88% |
| 2020 | ₩400.64 Million | +36.17% |
| 2019 | ₩294.22 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ChunLab Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.83 Million USD |
| MoneyControl | $71.83 Million USD |
| MarketWatch | $71.83 Million USD |
| marketcap.company | $71.83 Million USD |
| Reuters | $71.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.